[Evaluation of the therapeutic effectiveness of orally administered fenoterol in asthmatic children]. 1991

B Tafuro, and F Soffiati, and R Rubin, and P Pierfederici, and A Dall'Agnola
Divisione di Pediatria, USSL 28, Legnago, Verona, Italia.

In a single blind controlled trial we evaluated the effectiveness of fenoterol, administrated by oral route, in 14 pediatric patients, suffering from allergic asthma. The study was designed through three cycles of therapy: the first with fenoterol (0.25 mg/kg), the second with placebo and the third with the active drug again. The duration of each period was of one month and every two weeks a clinical and spirometric evaluation were performed. Positive data with statistically significant differences for the spirometric parameters were found together with a good safety and tolerability.

UI MeSH Term Description Entries
D008297 Male Males
D010366 Peak Expiratory Flow Rate Measurement of the maximum rate of airflow attained during a FORCED VITAL CAPACITY determination. Common abbreviations are PEFR and PFR. Expiratory Peak Flow Rate,Flow Rate, Peak Expiratory,PEFR
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D005280 Fenoterol A synthetic adrenergic beta-2 agonist that is used as a bronchodilator and tocolytic. Berotec,Berotek,Fenoterol Hydrobromide,Fenoterol Hydrochloride,Partusisten,Phenoterol,Th-1165a,p-Hydroxyphenyl-orciprenaline,p-Hydroxyphenylorciprenaline,Hydrochloride, Fenoterol,Th 1165a,Th1165a,p Hydroxyphenyl orciprenaline,p Hydroxyphenylorciprenaline
D005541 Forced Expiratory Volume Measure of the maximum amount of air that can be expelled in a given number of seconds during a FORCED VITAL CAPACITY determination . It is usually given as FEV followed by a subscript indicating the number of seconds over which the measurement is made, although it is sometimes given as a percentage of forced vital capacity. Forced Vital Capacity, Timed,Timed Vital Capacity,Vital Capacity, Timed,FEVt,Capacities, Timed Vital,Capacity, Timed Vital,Expiratory Volume, Forced,Expiratory Volumes, Forced,Forced Expiratory Volumes,Timed Vital Capacities,Vital Capacities, Timed,Volume, Forced Expiratory,Volumes, Forced Expiratory
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas
D016037 Single-Blind Method A method in which either the observer(s) or the subject(s) is kept ignorant of the group to which the subjects are assigned. Single-Masked Study,Single-Blind Study,Single-Masked Method,Method, Single-Blind,Method, Single-Masked,Methods, Single-Blind,Methods, Single-Masked,Single Blind Method,Single Blind Study,Single Masked Method,Single Masked Study,Single-Blind Methods,Single-Blind Studies,Single-Masked Methods,Single-Masked Studies,Studies, Single-Blind,Studies, Single-Masked,Study, Single-Blind,Study, Single-Masked

Related Publications

B Tafuro, and F Soffiati, and R Rubin, and P Pierfederici, and A Dall'Agnola
October 1982, The Journal of pediatrics,
B Tafuro, and F Soffiati, and R Rubin, and P Pierfederici, and A Dall'Agnola
July 1953, Journal of the American Medical Association,
B Tafuro, and F Soffiati, and R Rubin, and P Pierfederici, and A Dall'Agnola
June 1978, Chest,
B Tafuro, and F Soffiati, and R Rubin, and P Pierfederici, and A Dall'Agnola
January 2003, Jornal de pediatria,
B Tafuro, and F Soffiati, and R Rubin, and P Pierfederici, and A Dall'Agnola
October 1950, Science (New York, N.Y.),
B Tafuro, and F Soffiati, and R Rubin, and P Pierfederici, and A Dall'Agnola
May 1975, Virginia medical monthly,
B Tafuro, and F Soffiati, and R Rubin, and P Pierfederici, and A Dall'Agnola
January 1980, Developmental pharmacology and therapeutics,
B Tafuro, and F Soffiati, and R Rubin, and P Pierfederici, and A Dall'Agnola
July 1983, The Journal of pediatrics,
B Tafuro, and F Soffiati, and R Rubin, and P Pierfederici, and A Dall'Agnola
January 1968, The Journal of allergy,
B Tafuro, and F Soffiati, and R Rubin, and P Pierfederici, and A Dall'Agnola
December 1945, Comptes rendus des seances de la Societe de biologie et de ses filiales,
Copied contents to your clipboard!